| INTERACTION | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| ID | lncRNA Name | Interaction target | Level of interaction | Type of interaction | Description | PMID | Source | ||
| EL0555 | H19 | Igf2 of imprinted gene network (IGN) | RNA-Protein | regulation | We observed postnatal growth reduction in two independent transgenic lines and detected a decrease of Igf2 expression in embryos. An extensive analysis of several other genes from the newly described imprinted gene network (IGN) was performed in both loss- and gain-of-function animals. We found that H19 deletion leads to the upregulation of several genes of the IGN. | 19762426 | |||
| EL0555 | H19 | let-7 | RNA-RNA | binding | Acting as a molecular sponge, H19 inhibits microRNA (miRNA) let-7. | 25399420 | |||
| EL0555 | H19 | Igf2 (insulin-like growth factor 2) | RNA-DNA | regulation | This is associated with the disruption of igf2 imprinting and the consequent biallelic expression of this gene. | 9203585 | |||
| EL0556 | H19 | SERPINE1 | RNA-RNA | co-expression | Half-sbsRNA1 siRNA increased the levels of SERPINE1 and FLJ21870 mRNAs to 2-to-4.5-fold above normal. | 10738131 | |||
| EL0556 | H19 | IMP | RNA-Protein | binding | Human h19 rna contains four attachment sites for the oncofetal igf-ii mrna-binding protein (imp) | 10875929 | |||
| EL0556 | H19 | IMP-3 | RNA-Protein | regulation | Imp-3 protein associates with igf-ii leader-3 and leader-4 mrnas and h19 rna | 15753088 | |||
| EL0556 | H19 | miR-675 | RNA-RNA | co-expression | Recently, it was found that the H19 RNA is host to an exonic microRNA, miR-675, which, as a result, is also imprinted and maternally expressed. | 19239885 | LncRNADisease | ||
| EL0556 | H19 | c-myc | DNA-TF | regulation | H19 has been linked to the oncogene, c-myc, which positively regulates its expression in diverse cell types including T98G human glioblastoma cells. | 20380817 | LncRNADisease | ||
| EL0556 | H19 | p53 | DNA-TF | regulation | H19 has been linked to the tumor suppressor, p53, which negatively regulates its expression. | 20380817 | LncRNADisease | ||
| EL0556 | H19 | GLI1 | DNA-TF | regulation | H19 is a target of the GLI1 transcription factor, which mediates SHH signaling and is amplified more than 50-fold in human gliomas. | 20380817 | LncRNADisease | ||
| EL0556 | H19 | SHH | DNA-TF | regulation | H19 is a target of the GLI1 transcription factor, which mediates SHH signaling and is amplified more than 50-fold in human gliomas. | 20380817 | LncRNADisease | ||
| EL0556 | H19 | E2F1 | RNA-Protein | regulation | H19 transcription is positively regulated by the cell cycle regulatory factor, E2F1, during the S-phase of growth-stimulated cells. | 20380817 | LncRNADisease | ||
| EL0556 | H19 | Igf2 | RNA-RNA | co-expression | Complex functions, influences growth by down-regulating a number of imprinted genes including Igf2, also implicated as both a tumour suppressor and an oncogene. | 21256239 | LncRNADisease | ||
| EL0556 | H19 | CTCF1 | RNA-RNA | co-expression | Significant reductions at the H19 CTCF 1 and CTCF 2 binding sites were observed in the offspring of ethanol-treated sires, which was significantly correlated with reduced weight at postnatal days 35-42 (p?0.05). | 22395465 | LncRNADisease | ||
| EL0556 | H19 | CTCF2 | RNA-RNA | co-expression | Significant reductions at the H19 CTCF 1 and CTCF 2 binding sites were observed in the offspring of ethanol-treated sires, which was significantly correlated with reduced weight at postnatal days 35-42 (p<=0.05). | 22395465 | LncRNADisease | ||
| EL0556 | H19 | CTCF3 | RNA-RNA | co-expression | There is a CTCF-binding site (CTCF3) in the imprinting control region (ICR) upstream of H19. | 22395465 | LncRNADisease | ||
| EL0556 | H19 | IGF2 | RNA-Protein | regulation | H19 is an imprinted maternally expressed gene influencing IGF2 expression, whose transcript is a long noncoding (lnc) RNA of unknown biological function harboring the miR-675. | 22527881 | |||
| EL0556 | H19 | H19 transcript can counteract 91H-mediated Igf2 activation | RNA-RNA | regulation | A large excess of the H19 transcript can counteract 91H-mediated Igf2 activation. | 22662250 | |||
| EL0556 | H19 | Igf2 | RNA-Protein | regulation | Ectopic expression of the mouse 91H RNA can up-regulate Igf2 expression in trans | 22662250 | |||
| EL0556 | H19 | let-7 family of microRNAs | RNA-RNA | binding | Vertebrate H19 harbors both canonical and noncanonical binding sites for the let-7 family of microRNAs, which plays important roles in development, cancer, and metabolism. | 24055342 | |||
| EL0556 | H19 | H1.3 | RNA-Protein | regulation | H1.3dramatically inhibits H19 expression, which contributes to the suppression of epithelial ovarian carcinogenesis. | 25205099 | |||
| EL0556 | H19 | K homology-type splicing regulatory protein (KSRP) | RNA-Protein | binding | KSRP directly binds to H19 in the cytoplasm of undifferentiated multipotent mesenchymal C2C12 cells | 25385579 | |||
| EL0556 | H19 | miR-138 and miR-200a | RNA-RNA | regulation | by using bioinformatics study and RNA immunoprecipitation combined with luciferase reporter assays, we demonstrated that H19 functioned as a competing endogenous RNA (ceRNA) for miR-138 and miR-200a, antagonized their functions and led to the de-repression of their endogenous targets Vimentin, ZEB1, and ZEB2, all of which were core marker genes for mesenchymal cells | 26068968 | |||
| EL0556 | H19 | MiR-141 | RNA-RNA | binding | MiR-141 binds to H19 in a sequence specific manner, and suppresses H19 expression and functions including proliferation and invasion. MiR-141 could also regulate H19 target genes and miR-141 inhibitor restores H19 siRNA function, while H19 regulates miR-141 target gene ZEB1. | 26160158 | |||
| EL0556 | H19 | Yes-associated protein 1 (YAP1) | RNA-Protein | co-expression | H19 expression was found to be significantly associated with YAP1 expression. H19, at least in part, is induced by YAP1 overexpression. | 26163939 | |||
| EL0556 | H19 | miR-675 | RNA-RNA | regulation | Ectopic expression of H19 significantly increased bladder cancer cell proliferation and miR-675 expression in vitro. | 26198047 | |||
| EL0556 | H19 | histone deacetylase (HDAC) 4/5 | RNA-DNA | regulation | H19/miR-675 downregulated the mRNA and protein levels of histone deacetylase (HDAC) 4/5, and thus increased osteoblast marker gene expression. | 26417995 | |||
| EL0556 | H19 | transforming growth factor-β1 (TGF-β1) | RNA-DNA | regulation | H19/miR-675 inhibited mRNA and protein expression of transforming growth factor-β1 (TGF-β1). | 26417995 | |||
| EL0556 | H19 | c-Myc | RNA-Protein | regulation | H19 was a direct transcriptional target of c-Myc. | 26482621 | |||
| EL0556 | H19 | S-adenosylhomocysteine hydrolase (SAHH) | RNA-Protein | binding | The developmentally regulated H19 lncRNA binds to and inhibits S-adenosylhomocysteine hydrolase (SAHH), the only mammalian enzyme capable of hydrolysing S-adenosylhomocysteine (SAH) | 26687445 | |||
| EL0556 | H19 | c-Myc | DNA-DNA | regulation | The activity of the promoter of H19 was strengthened by c-Myc. | 26722426 | |||
| EL0556 | H19 | miR-107 | RNA-RNA | regulation | The expression of miR-107 increased or decreased with the overexpression and knockdown of H19, respectively. The number of cells in G2/M stage decreased significantly with the knockdown of H19 and miR-107 compared with the control group. | 26722426 | |||
| EL0556 | H19 | heterogeneous nuclear ribonucleoprotein (hnRNP) U and actin | RNA-Protein | regulation | H19 may inhibit the proliferation of fetal liver cells by blocking the interaction between heterogeneous nuclear ribonucleoprotein (hnRNP) U and actin, which results in gene transcriptional repression. | 26801864 | |||
| EL0556 | H19 | AKT2 | RNA-RNA | co-expression | The RNA levels of H19 and AKT2 were positively correlated. | 26803515 | |||
| EL0556 | H19 | miR-141 and miR-22 | RNA-RNA | binding | H19 functioned as an miRNA sponge for miR-141 and miR-22, both of which were negative regulators of osteogenesis and Wnt/β-catenin pathway. | 26853553 | |||
| EL0556 | H19 | HuR | RNA-Protein | regulation | H19 interacts with HuR and regulates the intestinal epithelial barrier function via the H19-encoded miR-675 by altering ZO-1 and E-cadherin expression posttranscriptionally. | 26884465 | |||
| EL0556 | H19 | miR-675 | RNA-RNA | regulation | H19 plays an important role in controlling the intestinal epithelial barrier function by serving as a precursor for microRNA 675 (miR-675). H19 overexpression increased the cellular abundance of miR-675, which in turn destabilized and repressed the translation of mRNAs encoding tight junction protein ZO-1 and adherens junction E-cadherin, resulting in the dysfunction of the epithelial barrier. | 26884465 | |||
| EL0556 | H19 | RUNX1 | RNA-DNA | regulation | Overexpression of H19 or miR-675 significantly decreased RUNX1 expression in AGS cells, and knockdown of H19 or miR-675 enhanced RUNX1 expression. | 26931432 | |||
| EL0556 | H19 | miR-675 | RNA-RNA | regulation | The expression of miR-675 was positively correlated with H19 in patients with gastric cancer. | 26931432 | |||
| EL0556 | H19 | eIF4A3 | RNA-Protein | binding | eIF4A3 as an RNA-binding protein that binds to H19. Combining eIF4A3 with H19 obstructed the recruitment of eIF4A3 to the cell-cycle gene mRNA. | 26989025 | |||
| EL0556 | H19 | EZH2 | RNA-DNA | regulation | H19 regulated EZH2 expression by suppressing the activity of miR-630, which is a repressor of EZH2 and interacts with H19 in a sequence-specific manner. | 27040767 | |||
| EL0556 | H19 | miR-630 | RNA-RNA | regulation | H19 regulated EZH2 expression by suppressing the activity of miR-630, which is a repressor of EZH2 and interacts with H19 in a sequence-specific manner. | 27040767 | |||
| EL0556 | H19 | CaMKIIδ | RNA-Protein | regulation | CaMKIIδ was a direct target of miR-675 and partially mediated the effect of H19 on cardiomyocyte hypertrophy. | 27084844 | |||
| EL0556 | H19 | miR-675 | RNA-RNA | regulation | H19 encoded miR-675. | 27084844 | |||